Evan Pierce Stiegel, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1450 Professional Park Dr Ste 150, Winston Salem, NC 27103 Phone: 336-724-2434 |
Steven Richard Feldman, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4618 Country Club Rd, Winston Salem, NC 27104 Phone: 336-716-3926 Fax: 336-716-9258 |
Dr. Kevin Raymond Stein, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1450 Professional Park Dr, Ste 150, Winston Salem, NC 27103 Phone: 336-724-2434 Fax: 336-724-6123 |
Nicholas Sebes, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1450 Professional Park Dr Ste 150, Winston Salem, NC 27103 Phone: 336-724-2434 Fax: 336-607-8061 |
Stephanie Bialas Sturgill, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 175 Kimel Park Dr, Dba Winston-salem Healthcare, Winston Salem, NC 27103 Phone: 336-718-1006 |
Dr. Paul Douglass Wortman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 127 S Poplar St, Winston Salem, NC 27101 Phone: 336-893-8423 Fax: 336-893-8426 |
Paul J Kostuchenko, MD Dermatology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 1345 Westgate Center Dr Ste B, Winston Salem, NC 27103 Phone: 336-768-1280 Fax: 336-760-8443 |
Zeynep Meltem Akkurt, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4618 Country Club Rd, Winston Salem, NC 27104 Phone: 367-163-9263 Fax: 336-716-9258 |
News Archive
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
Imprimis Pharmaceuticals, Inc., which is focused on the commercialization of compounded drug formulations utilizing the FDA 505(b)(2) development pathway, today announced it has received IRB approval for its Phase III clinical trial protocol of its lead product candidate, Impracor.
Charis Eng, M.D., Ph.D., of Cleveland Clinic and her team have discovered that a faulty, rarely studied gene called USF3 may predispose individuals to thyroid cancer. They recently published this discovery in Human Molecular Genetics.
Chinese and WHO officials last week agreed to open a flu research center in Beijing, Bloomberg reports. "The new collaborating center for reference and research on influenza will join a network of WHO-affiliated labs in Atlanta, London, Tokyo and Melbourne that monitor flu strains and make recommendations on vaccines to fight the virus," the news service writes
› Verified 7 days ago